Related Experiment Video
Updated: Jan 27, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years
Frank Tacke1, Martina E Spehlmann2, Mihael Vucur1
1Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Introduction:
Alterations in miR-155 serum levels have been described in inflammatory and infectious diseases. Moreover, a role for miR-155 in aging and age-related diseases was recently suggested. We therefore analyzed a potential age-dependent prognostic value of circulating miR-155 as a serum-based marker in critical illness.
Methods:
Concentrations of circulating miR-155 were determined in 218 critically ill patients and 76 healthy controls.
Results:
By using qPCR, we demonstrate that miR-155 serum levels are elevated in patients with critical illness when compared to controls. Notably, levels of circulating miR-155 were independent on the severity of disease, the disease etiology, or the presence of sepsis. In the total cohort, miR-155 was not an indicator for patient survival. Intriguingly, when patients were subdivided according to their age upon admission to the ICU into those younger than 65 years, lower levels of miR-155 turned out as a strong marker, indicating patient mortality with a similar accuracy than other markers frequently used to evaluate critically ill patients on a medical ICU.
Conclusion:
In summary, the data provided within this study suggest an age-specific role of miR-155 as a prognostic biomarker in patients younger than 65 years. Our study is the first to describe an age-dependent miRNA-based prognostic biomarker in human diseases.
Insights
Circulating miR-155 serum levels are elevated in critical illness. Lower miR-155 levels in patients under 65 predict mortality, suggesting an age-specific prognostic biomarker for critical care.
Area of Science:
- Biomarkers
- Critical Care Medicine
- Molecular Biology
Background:
- MicroRNA-155 (miR-155) serum levels are altered in inflammatory and infectious diseases.
- A potential role for miR-155 in aging and age-related diseases has been suggested.
- Investigating miR-155's prognostic value in critical illness is warranted.
Purpose of the Study:
- To analyze the age-dependent prognostic value of circulating miR-155 in critical illness.
- To evaluate miR-155 as a serum-based biomarker for patient outcomes.
- To determine if miR-155 levels correlate with disease severity or sepsis.
Main Methods:
- Quantitative PCR (qPCR) was used to measure serum miR-155 concentrations.
- A cohort of 218 critically ill patients and 76 healthy controls was studied.
- Patients were stratified by age (younger than 65 years) for subgroup analysis.
Main Results:
- Serum miR-155 levels were significantly elevated in critically ill patients compared to controls.
- miR-155 levels were independent of disease severity, etiology, or sepsis presence.
- In patients younger than 65, lower miR-155 levels accurately predicted mortality.
Conclusions:
- Circulating miR-155 demonstrates an age-specific prognostic role in critical illness, particularly in patients under 65.
- This study identifies the first age-dependent microRNA-based prognostic biomarker in human diseases.
- miR-155 may serve as a valuable tool for predicting mortality in younger critically ill patients.
More Related Videos
Related Concept Videos
Predicting Molecular Geometry
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
Critical Values
Critical Thinking
Colleges and universities are...
Critical Thinking I
Critical Thinking II

